Comparison of Tenofovir Disoproxil Fumarate and Entecavir in the Prophylaxis of HBV Reactivation

dc.date.accessioned	2020-10-21T06:44:40Z
dc.date.available	2020-10-21T06:44:40Z
dc.date.issued	2020
dc.date.issued	2020/07/31
dc.identifier.citation	Koksal AS, Eminler AT, Tozlu M.Dig Dis Sci. 2020 Jul 29. doi: 10.1007/s10620-020-06506-w. Online ahead of print.
dc.identifier.uri	http://doi.org/10.1007/s10620-020-06506-w
dc.identifier.uri	https://hdl.handle.net/20.500.12619/71240
dc.description	PMID = 32729014
dc.relation.isversionof	10.1007/s10620-020-06506-w
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Comparison of Tenofovir Disoproxil Fumarate and Entecavir in the Prophylaxis of HBV Reactivation
dc.type	article
dc.relation.journal	Dig Dis Sci
dc.identifier.doi	10.1007/s10620-020-06506-w
dc.contributor.author	Toka B
dc.contributor.author	Koksal AS
dc.contributor.author	Eminler AT
dc.contributor.author	Tozlu M
dc.contributor.author	Uslan MI
dc.contributor.author	Parlak E.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi